Armer Thomas A
Chief Scientific Officer at MAP Pharmaceuticals, Inc.
- Sold, on record
- $4.5M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Jan 23, 2013
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MAP Pharmaceuticals, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MAP Pharmaceuticals, Inc.Plan not statedMay 27, 2009 2009
Sold 100,000 shares at $9.61 ($961k)
Armer Thomas A, Chief Scientific Officer
Sold 23.1% of holdings ($4.2M position)332,403 shares leftFirst sale on recordFiling
- 2 Form 4 sale MAP Pharmaceuticals, Inc.Plan not statedDec 14, 2009 +201 days
Sold 10,000 shares at $9.54 ($95k)
Armer Thomas A, Chief Scientific Officer
Sold 2.9% of holdings ($3.3M position)332,403 shares leftFiling
- 3 Form 4 sale MAP Pharmaceuticals, Inc.Plan not statedMar 4, 2011 +445 days
Sold 30,000 shares at $16.10 ($483k)
Armer Thomas A, Chief Scientific Officer
Sold 12.4% of holdings ($3.9M position)212,009 shares leftFiling
- 4 Form 4 sale MAP Pharmaceuticals, Inc.Plan not statedDec 19, 2011 +290 days
Sold 20,000 shares at $14.00 ($280k)
Armer Thomas A, Officer, Director
Sold 8.1% of holdings ($3.5M position)227,855 shares leftFiling
- 5 Form 4 sale MAP Pharmaceuticals, Inc.Plan not statedFeb 6, 2012 +49 days
Sold 20,000 shares at $15.00 ($300k)
Armer Thomas A, Chief Scientific Officer
Sold 8.7% of holdings ($3.4M position)209,162 shares leftFiling
- 6 Form 4 sale MAP Pharmaceuticals, Inc.Plan not statedFeb 8, 2012 +2 days
Sold 26,201 shares at $16.00 ($419k)
Armer Thomas A, Chief Scientific Officer
Sold 12.5% of holdings ($3.3M position)182,961 shares left1.3x usual sizeFiling
- 7 Form 4 sale MAP Pharmaceuticals, Inc.Plan not statedFeb 14, 2012 +6 days
Sold 33,799 shares at $15.65 ($529k)
Armer Thomas A, Chief Scientific Officer
Sold 18.5% of holdings ($2.9M position)149,162 shares left1.5x usual sizeFiling
- 8 Form 4 sale MAP Pharmaceuticals, Inc.UnusualJan 23, 2013 +344 days
Sold 59,620 shares at $24.76 ($1.5M)
Armer Thomas A, Chief Scientific Officer
Sold 31.6% of holdings ($4.7M position)129,162 shares left2.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2013 | Jan 25, 2013 | MAP Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 59,620 | $1.5M | 31.6% | Unusual | SEC |
| Feb 14, 2012 | Feb 14, 2012 | MAP Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 33,799 | $529k | 18.5% | Plan not stated | SEC |
| Feb 8, 2012 | Feb 10, 2012 | MAP Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 26,201 | $419k | 12.5% | Plan not stated | SEC |
| Feb 6, 2012 | Feb 7, 2012 | MAP Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 20,000 | $300k | 8.7% | Plan not stated | SEC |
| Dec 19, 2011 | Dec 21, 2011 | MAP Pharmaceuticals, Inc. | Officer, Director | Form 4 sale | 20,000 | $280k | 8.1% | Plan not stated | SEC |
| Mar 4, 2011 | Mar 8, 2011 | MAP Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 30,000 | $483k | 12.4% | Plan not stated | SEC |
| Dec 14, 2009 | Dec 16, 2009 | MAP Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 10,000 | $95k | 2.9% | Plan not stated | SEC |
| May 27, 2009 | May 28, 2009 | MAP Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 100,000 | $961k | 23.1% | Plan not stated | SEC |